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Abstract
Background Throughout recent decades there has been
noticeable change in the incidence of peptic ulcer disease
and its complications. The aim of the present study was to
determine the character of changes over the last 45 years in
the localization of perforation, in patient age, and in patient
gender.
Methods A group of 881 patients admitted to the Second
Department of General Surgery in Krakow, Poland, from
1962 to 2006 were included in the study and constituted the
material for the analysis. The study was divided into three
time periods (1962–1976, 1977–1991, and 1992–2006) to
allow statistical analysis of trends.
Results The general incidence of perforations of peptic
ulcer did not show changes; however, the percentage of
women with perforated duodenal ulcer markedly increased.
Patients with perforated stomach ulcer—regardless of
gender—and females suffering from perforated duodenal
ulcer were, on the average, about 10 years older than males
with perforated duodenal ulcers. The mean age of male and
female patients with perforated duodenal ulcer over the last
45 years showed an insigniﬁcant upward trend.
Conclusions (1) The percentage of women with perfo-
rated duodenal ulcer continuously and statistically signiﬁ-
cantly rose. (2) Men with perforated duodenal ulcer were
signiﬁcantly younger than other patients. (3) The mean
ages of male and female patients with perforated duodenal
ulcer over the last 45 years showed an insigniﬁcant upward
trend.
Introduction
Epidemiological research on uncomplicated peptic ulcer
disease is methodically difﬁcult and thus not free from
mistakes. One of the causes of such a situation is a diverse
clinical course of peptic ulcer disease, with mutable
intensity of complaints and the presence of interweaving
periods of relapse and remissions of different duration.
Another problem results from changes in the diagnostic
workup conﬁrming peptic ulcer that evolved from clinical
assessment alone, through radiological examination, to
gastroscopy, which nowadays constitutes the diagnostic
method of choice. Altogether, these are the reasons for
difﬁculty in comparing the present incidence of the disease
with the morbidity recorded in the past. Another problem
affecting the precision of epidemiological research is the
presence of still-improving pharmaceutical agents that
have led to a marked decrease in the number of patients
hospitalized for the treatment of peptic ulcer. Moreover,
there is still a large group of young patients being treated
only on the basis of clinical assessment, without gastros-
copy conﬁrming the ulcer and its location [1–6].
The situation is different in cases of complications of
peptic ulcer disease that usually cause severe complaints
and constitute an indication for hospitalization. Similarly,
in cases of bleeding ulcer and stenosis of the gastric outlet,
the complaints usually lead to hospitalization. Neverthe-
less, both diagnostic and therapeutic approaches have
changed so much during the last half century that present
observations cannot be compared with previous ones.
Perforation of peptic ulcer constitutes a unique situation
characterized by severe pain, leading almost every patient
with this complication to seek help in the hospital. On the
basis of criteria that have remained invariable for decades,
such patients are, as a rule, treated surgically, and that not
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precise localization of the ulcer as well, thus making pos-
sible comparison of data collected over many years.
Determination of changes in the localization of perfo-
rated peptic ulcer and variations in gender and age of the
patients over the last 45 years constituted the aim of the
present study.
Materials and methods
Between 1 January 1962 and 31 December 2006, 871
patients underwent operation for perforated peptic ulcer in
the Second Department of General Surgery of Jagiellonian
University Medical College in Krakow. In another ten
patients admitted in a terminal state, the diagnosis of per-
foration was made at autopsy. In the whole group of 881
patients included in the study, there were 776 cases of per-
forated duodenal ulcer and 105 cases of perforated stomach
ulcer. There were 672 male and 209 female patients.
Ourreferralpopulationwasnotdemographicallyconstant
forthewhole45 yearsofthestudyperiod.However,withthe
increaseintheheadcountofthepopulationofKrakowcame
the foundation of new hospitals admitting acute surgical
cases in the same area. Thus the number of patients with
acute surgical diseases treated in the Second Department of
GeneralSurgery ofJagiellonian UniversityMedical College
in Krakow remained on comparable level until 2002. Dif-
ferences in the incidence of gastric ulcer calculated for this
population did not differ signiﬁcantly. In women the inci-
dence increased from 0.8 to 1.2/100,000/year, whereas, in
men, the incidence decreased from 3.4 to 2.3. Simulta-
neously the incidence of duodenal ulcer in the male popu-
lation decreased from 29.6 to 22.7 (difference insigniﬁcant
statistically), whereas in the female population it increased
signiﬁcantlyfrom3.5to9.4.Unfortunately,becauseofsome
more pronounced changes in the referral population and the
structureof the medical service from 2003 to the present,we
werenotabletocalculatetheexactincidenceandpresentitin
ourstudy.Theobservationtimeof45 yearswasdividedinto
threeperiods:1962–1976(15 years),1977–1991(15 years),
and 1992–2006 (15 years). Calculations were made sepa-
rately for each gender and for stomach ulcers and duodenal
ulcers. Student’s t test and the v
2 test were used in statistical
assessment.
Results
Localization
Throughout the 45-year observation time, perforation of
duodenal ulcer proved to be more than seven times more
frequent than perforation of stomach ulcer when calculated
together for both sexes. Differences among particular
periods of the study were slight and did not show statistical
signiﬁcance (Table 1).
Gender
There was an increase in the percentage of women in the
group of patients with perforated duodenal ulcer observed
in consecutive periods of the study (Table 2). Differences
in the proportion of female patients between the third
and the second periods and between the third and the
ﬁrst periods were statistically signiﬁcant (P\0.01). An
increase in the percentage of women between the ﬁrst and
the second periods also proved signiﬁcant (P\0.05).
There were no statistically signiﬁcant differences
observed in gender distribution of perforated gastric ulcer
(Table 3).
Table 1 Localization of perforated peptic ulcer
Period Duodenal
ulcer n (%)
Stomach
ulcer n (%)
Together
n
I (1962–1976) 227 (87.6) 21 (12.4)
a 259
II (1977–1991) 249 (86.5) 39 (13.5)
b 288
III (1992–2006) 300 (89.8) 34 (10.2)
c 334
I ? II ? III 776 (88.1) 105 (11.9) 881
a/b, a/c, and b/c differences without statistical signiﬁcance
Table 2 Gender differences in perforated duodenal ulcer
Period Male
patients n (%)
Female
patients n (%)
Together
n
I (1962–1976) 199 (87.7) 28 (12.3)
a 227
II (1977–1991) 200 (80.3) 49 (19.7)
b 249
III (1992–2006) 203 (67.7) 97 (32.3)
c 300
I ? II ? III 602 (77.6) 174 (22.4) 776
a/b difference with statistical signiﬁcance (P\0.05)
a/c and b/c differences with statistical signiﬁcance (P\0.01)
Table 3 Gender differences in perforated stomach ulcer
Period Male
patients n (%)
Female
patients n (%)
Together
n
I (1962–1976) 21 (65.6) 11 (34.4)
a 32
II (1977–1991) 27 (69.2) 12 (30.8)
b 39
III (1992–2006) 22 (64.7) 12 (35.3)
c 34
I ? II ? III 70 (66.7) 35 (33.3) 105
a/b, a/c, and b/c differences without statistical signiﬁcance
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Mean ages of both male and female patients with perfo-
rated duodenal ulcer presented an upward trend; however,
that trend was without statistical signiﬁcance (Tables 4, 5).
The mean age of the female patients in every period of the
study (a/d, b/e, c/f and for the study as a whole) was sig-
niﬁcantly higher than mean age of the male patients at
P\0.001. Mean ages for both sexes showed an upward
trend; however, this regularity did not prove to be statis-
tically signiﬁcant.
Only the mean age of women with perforated stomach
ulcer in the third period (a/b in Table 5) was signiﬁcantly
higher than in the second period (P\0.05). Otherwise,
changes in the age of male and female patients did
not show statistical signiﬁcance. Mean age of female
patients—except for the second period—was insigniﬁ-
cantly higher than the mean age of male patients, although
the mean age of men showed an upward trend.
Men with perforated stomach ulcer were signiﬁcantly
older than men with duodenal ulcer at P\0.05 for the ﬁrst
and the third periods, and at P\0.001 for the second
period. Women with perforated stomach ulcer were only
2 years older than women with duodenal ulcer, and this
difference showed no signiﬁcance, either for the whole
group or for particular periods.
For whole study period women with perforated duode-
nal ulcer were more than 12 years older than men
(P\0.001). Mean ages of female patients with duodenal
and stomach ulcers were similar. The 9-year difference
between the groups of male patients with duodenal and
stomach ulcers proved to be statistically signiﬁcant
(P\0.01). In the group of patients with perforated stom-
ach ulcer, women were more than 6 years older than men,
but this difference proved insigniﬁcant.
Discussion
Jan Mikulicz Radecki, professor of surgery at Jagiellonian
University at that time, was mentioned in the literature as
the ﬁrst surgeon who had sutured a perforated ulcer [7].
This statement requires correction—in 1885, during the
Congress of Naturalists in Magdeburg, Radecki presented
the case of a patient he had operated on in Theodor Bill-
roth’s department in Vienna. Precise description of the case
includes a 7-cm-long subcardial rupture of the gastric wall
and not a perforated ulcer. The lecture was published in the
same year in a Cracovian paper titled ‘‘Przegla ˛d Lekarski’’
[8]. Ludwik Heuser in Wuppertal and Hastings Gilford in
England in 1892 were truly the ﬁrst surgeons who suc-
cessfully closed perforated ulcers [9].
Age and gender of the patients and localization of per-
foration have changed over the years. For example in the
middle of the nineteenth century in England perforation in
the subcardial region dominated, with young women being
themostcommonlyaffectedgroupofpatients[10].Inrecent
years there has been a marked change in the incidence of
pepticulcerdiseaseobservedinmanycountries[5,6,11–14].
Startinginthe1980stherehasbeen amarkeddecreaseinthe
number of hospitalizations due to peptic ulcer disease. This
change is related to the introduction of modern pharmaco-
therapy, initially based on H2-blockers, and later modiﬁed
(with the use of proton pump inhibitors [PPIs], which were
introduced in 1988) and supplemented with the use of
eradication of Helicobacter pylori [5, 6, 14–18]. The
decrease in hospitalizations was also a result of ambulatory
treatment of uncomplicated peptic ulcer disease. However,
despite the use of more and more effective drugs, there was
notacomparabledecreaseinthenumberofcomplicationsof
this disease [6, 14, 16, 18, 19]. In fact, the incidence of
complications such as hemorrhage and perforation has
ﬂuctuated for years, and marked differences were observed
among the various countries and time periods reported [11,
13, 15, 16, 20–27]. Along with the downward trend in per-
forations observed in Europe, there was marked increase in
the number of perforations observed elsewhere—e.g., in
Hong-Kong [14, 21, 24, 26, 27]. Even within a single
country there were signiﬁcant differences between regions
(even those close to one another) [20]. Causes of such
observations cannot be unequivocally explained; however,
the literature suggests a role for changes in dietary customs,
smoking habits, and a continuing increase in the use of non-
steroidal anti-inﬂammatory drugs (NSAIDs) [3, 28–31].
Table 4 Mean age of patients with perforated duodenal ulcer
Period Male patients age,
years (SD)
Female patients age,
years (SD)
I (1962–1976) 44.5 (16.4)
a 55.04 (13.98)
d
II (1977–1991) 45.8 (17.1)
b 57.7 (20.7)
e
III (1992–2006) 47.2 (16.2)
c 60.6 (18.97)
f
I ? II ? III 45.85 (16.6) 58.89 (18.8)
a/d, b/e, c/f and for whole study group differences with statistical
signiﬁcance (P\0.001)
Table 5 Mean age of patients with perforated stomach ulcer
Period Male patients age,
years (SD)
Female patients age,
years (SD)
I (1962–1976) 51.1 (12.8) 59.5 (21.6)
II (1977–1991) 57.6 (12.7) 54.25 (17.05)
a
III (1992–2006) 56.95 (15.8)
c 69.25 (17.9)
b
I ? II ? III 55.47 (13.86) 61.06 (19.39)
a/b difference with statistical signiﬁcance (P\0.05)
World J Surg (2011) 35:811–816 813
123Differences concern the general incidence of ulcer and
its changes in time, gender proportion, localization of
the ulcer and, ﬁnally, the age of the patients [5, 21, 27, 30,
32–35]. Changes in the number of perforations in consec-
utive decades can be explained by the fact that cohorts of
people born at the beginning of the twentieth century were
more likely to suffer from perforation than people born
later [36]. This statement is conﬁrmed by the epidemio-
logical observations of the population of Iceland, which
represents a closed population that does not undergo
marked ﬂuctuations. Those studies conﬁrmed the highest
risk of perforation in the group of people born during the
ﬁrst and the second decades of the twentieth century. In
Iceland those generations had the highest prevalence of H.
pylori antibodies [37].
Nowadays perforations of duodenal ulcer are found
mostly in men; however, there has been an increase in the
proportion of women [13, 15, 17–19, 38]. Such a trend was
also observed in the second half of the twentieth century in
Norway [36]. In many studies, coming mostly from Great
Britain, authors pay attention to the decrease in the number
of ulcer perforations with the concomitant increase in the
proportion of elderly women suffering from this compli-
cation [15, 17, 18, 26, 27, 32, 33, 39, 40]. Those changes
are related to different factors, including among others,
dietary habits (difﬁcult to conﬁrm), including alcohol use.
Smoking also seems to play an important role as a causa-
tive factor [18, 22, 39, 41]. However, the incidence of ulcer
perforations is inﬂuenced the most by the use of NSAIDs,
which increase the risk of perforation 6–8 times [11, 13, 22,
39, 41, 42]. The use of NSAIDs among older women is
widespread and still rising, conﬁrming strong relationship
between the use of NSAIDs and the incidence of compli-
cations of peptic ulcer disease [13, 22, 27–29, 43].
Helicobacter pylori infection—so important in the patho-
genesis of uncomplicated peptic ulcer disease—did not
prove to play an important role in perforations. In some
studies the percentage of infected patients in the group
suffering from perforation amounted to about 20% [39].
Other studies, however, found a low percentage of patients
infected with H. pylori only in the group of people taking
NSAIDs, whereas in the remaining patients the incidence
of H. pylori infection was similar to the group of uncom-
plicated peptic ulcer disease [44, 45]. The abovementioned
epidemiological study from Iceland also indicates the
important role of H. pylori infection [37]. It seems that
marked differences in the percentage of patients with per-
forated peptic ulcer infected by H. pylori can result from
the way in which this infection is conﬁrmed [44].
The percentage of women among patients with perfo-
rated duodenal ulcer throughout the 45 years of the study
increased almost threefold (from 12.3 to 32.3%). This
observation cannot be explained only by the longer lifespan
of women. In our study an average expected lifespan for
both gender groups has increased. In Poland, the expected
lifespan for men was about 67 years for the ﬁrst study
period and reached 71 for the last (almost 6% increase). In
the group of Polish women, mean lifespan also increased—
from almost 75 years for the ﬁrst study period to almost
80 years for the last one (about a 6% increase). Differences
in lifespan between men and women did not, however,
prove signiﬁcant. Therefore the increasing prevalence of
ulcer disease in elderly women does not reﬂect the longer
lifespan of women.
For almost half a century there was an increase in the
proportion of women with perforated duodenal ulcer
observed in our study. Thus for such localization of per-
foration, the male to female ratio changed from about 7:1
to slightly more than 2:1. Similar observations were also
found in other studies [6, 15, 19], but still others did not
reveal such results [13, 17, 18].
According to our data, the mean age of women with
perforated stomach ulcer did not differ signiﬁcantly from
women with perforation of duodenal ulcer. Their mean age
was also similar to the mean age of male patients with
perforated stomach ulcer. Only men with perforated duo-
denal ulcer presented with signiﬁcantly lower mean age as
compared to the above mentioned groups. Similar differ-
ences were observed in the study from England that found
the mean age of women with perforated duodenal ulcer to
be 10 years higher than the mean age of men [15]. How-
ever, that study presented a markedly older population than
ours, with the mean age of male patients of 67.6 years and
that of female patients of 77.6 years [39]. Most of the
recent studies revealed a marked increase in the mean age
of patients admitted to the hospital for complications of
peptic ulcer disease, including perforations [5, 15, 17–19].
Similar results, although without statistical signiﬁcance,
were found in our material.
The introduction of more and more potent anti-ulcer
drugs, including eradication of H. pylori, proved effective
enough to decrease the number of patients hospitalized and
treated for uncomplicated peptic ulcer disease. At present,
only patients presenting with complications are treated
surgically [1, 30, 32, 46, 47]. It is, however, believed
that—in the general population—modern treatment of
peptic ulcer disease did not cause the signiﬁcant decrease
in the number of complications [34, 46, 47]. Such a
statement can, however, be revised, because recent studies
from Spain, Sweden, Italy, and Taiwan indicate that from
the time of introduction of PPIs the number of perforations
markedly decreased [6, 16, 18, 25].
In summary, it is possible to state that divergence
between results of the studies on the incidence, character-
istics of patients, and localization of perforated ulcer are
related to the multifactorial pathogenesis of this
814 World J Surg (2011) 35:811–816
123complication of peptic disease, including regional differ-
ences of dietary customs, smoking habits, and prevalence
of the use of NSAIDs.
Conclusions
The percentage of women with perforated duodenal ulcer
continuously and statistically signiﬁcantly rises. Men with
perforated duodenal ulcer were signiﬁcantly younger than
women with this complication and than patients with per-
forated stomach ulcer regardless of gender. Mean ages of
male and female patients with perforated duodenal ulcer
over the last 45 years showed an insigniﬁcant upward trend.
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